Argent BioPharma Limited (RGT.L) Stock Price
£6 0%
to add to portfolio
AI Score

-
Alternative
8 -
Fundamental
0 -
Technical
1
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Argent BioPharma Limited, AI stock picks, stock alerts and much more.
RGT.L AI Stock Analysis
AI stock analysis for RGT.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Argent BioPharma Limited (RGT.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Argent BioPharma Limited (RGT.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Argent BioPharma Limited (RGT.L), currently trading at £6, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About RGT.L

-
.
-
Symbol
RGT.L
-
Market
LSE
-
Industry
-
Market Cap
4.2M
Similar Stocks
![]() |
LEVERAGE SHARES PUBLIC LIMITED GOOG.L |
£643.4 1.5% |
6 |
![]() |
LEVERAGE SHARES PUBLIC LIMITED AMZN.L |
£587.2 1.8% |
7 |
![]() |
LEVERAGE SHARES PUBLIC LIMITED AMZ1.L |
€7.03 1.4% |
7 |
![]() |
Buffettique Growth ETP BUFE.L |
€18.11 0.4% |
6 |
![]() |
Wahed FTSE USA Shariah ETP HLA1.L |
$15.56 0.4% |
6 |
News
RGT.L Alternative Data
News Mentions
Argent BioPharma Limited was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Argent BioPharma Limited has 22 Twitter Followers on its main Twitter (also known as X) account, which is up by 4.8% over the last month.
-
Twitter Followers
22
-
Daily Change
0%
-
1 Month Change
4.8%
-
3 Month Change
72.5%
Facebook Engagement
Argent BioPharma Limited has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Argent BioPharma Limited has 31 employees, down by -3.1% over the last month.
-
LinkedIn Employees
31
-
Daily Change
0%
-
1 Month Change
3.1%
-
3 Month Change
3.3%
RGT.L Financials
RGT.L Key Metrics
-
Total Revenue
A$153.8K
-
Net Income
-A$5.5M
-
Earnings per Share
-A$0.11
-
Free cash flow
-A$3.6M
-
EBITDA
-A$5M
-
EBITDA Ratio
-32.4328
-
Total Assets
A$10.8M
RGT.L 2-year Revenue & Income
RGT.L 2-year Free Cash Flow
RGT.L Technicals
RGT.L SMA
RGT.L RSI
FAQ
What's the current price of Argent BioPharma Limited (RGT.L) Stock?
The price of an Argent BioPharma Limited (RGT.L) share is £6.
What's the market cap of Argent BioPharma Limited?
The current market cap of Argent BioPharma Limited is 4.2M.
Should I buy or sell RGT.L?
Argent BioPharma Limited exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Argent BioPharma Limited a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Argent BioPharma Limited stock. There are several bearish signals and market challenges that could negatively impact Argent BioPharma Limited's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Argent BioPharma Limited (RGT.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Argent BioPharma Limited stock right now, as the outlook appears bearish.
What are some stocks similar to Argent BioPharma Limited (RGT.L) that investors often compare it to?
Argent BioPharma Limited (RGT.L) is often compared to similar stocks such as LEVERAGE SHARES PUBLIC LIMITED , LEVERAGE SHARES PUBLIC LIMITED , LEVERAGE SHARES PUBLIC LIMITED , Buffettique Growth ETP and Wahed FTSE USA Shariah ETP.
What is the forecast for Argent BioPharma Limited's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Argent BioPharma Limited's stock price to be around £5.53 in 2026. Starting from the current price of £6, this represents a 7.9% change in price, indicating a bearish outlook for the stock.
How to buy Argent BioPharma Limited (RGT.L) Stock?
Argent BioPharma Limited stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Argent BioPharma Limited shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.